← MOLECULAR PARTNERS AG MOLN
Market Price
$4.11
Market Cap
$161.50M
P/E Ratio
N/A
Revenue (FY 2025)
↓-100.0% YoY
N/A
Full year reported
Net Income
↓-14.1% YoY
-$61.65M
Net Margin: N/A
Free Cash Flow
↓-2.5% YoY
-$696.00K
FCF Yield: -0.43%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
-76.7%
ROA: -60.4%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MOLN)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2018 | — | — | — | — | — | — | — | — | — | — |
| FY 2019 | $20.4M | — | $20.4M | $-36.3M | — | — | — | $-0.1M | $-1.1M | — |
| FY 2020 | $9.3M | -54.2% | $9.3M | $-62.8M | -73.1% | — | — | $0.2M | $-1.2M | -9.8% |
| FY 2021 | $9.8M | +4.4% | $9.7M | $-63.8M | -1.6% | — | — | $0.6M | $-0.3M | +71.6% |
| FY 2022 | $189.6M | +1,843.8% | $189.0M | $117.9M | +284.8% | — | — | $0.6M | $-0.5M | -51.7% |
| FY 2023 | $7.0M | -96.3% | $7.0M | $-62.0M | -152.6% | — | — | $0.0M | $-0.5M | -1.9% |
| FY 2024 | $5.0M | -29.4% | $4.9M | $-54.0M | +12.8% | — | — | $0.0M | $-0.7M | -25.5% |
| FY 2025 | — | -100.0% | — | $-61.6M | -14.1% | — | — | $0.0M | $-0.7M | -2.5% |
Valuation
Market Price
$4.11
Market Cap
$161.50M
Enterprise Value
$84.93M
P/E Ratio
N/A
P/B Ratio
2.07
FCF Yield
-0.43%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity (ROE)
-76.74%
Return on Assets (ROA)
-60.38%
Asset Turnover
0.00x
Revenue 3-Yr CAGR
N/A
Financial Health & Liquidity
Current Ratio
9.02
Cash Ratio
7.69
Debt / Equity
0.076
Debt / Assets
0.060
Cash & Equivalents
$82.65M
Total Debt
$6.08M
Book Value / Share
$1.99
Cash Flow Efficiency
Operating Cash Flow
$18.00K
Capital Expenditures (CapEx)
$714.00K
Free Cash Flow
-$696.00K
OCF / Revenue
N/A
FCF / Revenue
N/A
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$1.99
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$102.11M
Total Liabilities
$21.77M
Stockholders' Equity
$80.33M
Current Assets
$96.88M
Current Liabilities
$10.75M